An 18-Month Ban, a Twin Brother and an Inhaler: India's Swimming Team Loses an Asian Games 2026 Slot
**Câu trả lời cốt lõi:** Một VĐV bơi nam 17 tuổi người Ấn Độ bị treo giò 18 tháng và bị rút khỏi đội dự Asian Games 2026 tại Aichi–Nagoya vì dương tính terbutaline, hoạt chất xịt hen không có ngưỡng cho phép. Anh khai báo chất này trên phiếu kiểm soát doping nhưng không có giấy miễn trừ điều trị hợp lệ. **Dữ kiện chính:** - VĐV dương tính terbutaline trong mẫu lấy tháng 2/2026; liên đoàn rút tên khỏi Commonwealth Games rồi Asian Games. - Án tiêu chuẩn là 4 năm; mức 18 tháng cho thấy hội đồng chấp nhận không cố ý nhưng vẫn quy một phần lỗi. - Anh bị ngộ độc khói, dùng thuốc theo chỉ định bác sĩ, nhưng không xin giấy miễn trừ điều trị trước khi sử dụng. - Anh trai sinh đôi vẫn còn suất dự Asian Games; cả hai từng thi đấu giải trẻ quốc tế với tên khác nhau một chữ cái. - Ấn Độ dẫn đầu thế giới về số vi phạm chống doping nhiều năm liên tiếp, nhưng chỉ giành 6 huy chương, không có vàng, tại Olympic Paris 2024. **Nguồn:** Times of India (dẫn lại bởi các đầu báo Ấn Độ) — bản gốc không nêu ngày công bố; dữ kiện ngộ độc khói, đơn thuốc và án 18 tháng theo Times of India. | Cross-checked: VuaBong.vn **Hỏi đáp liên quan:** H: Terbutaline bị cấm vì lý do gì? Đ: Terbutaline thuộc nhóm beta-2 agonist (danh mục S3), bị WADA cấm ở mọi nồng độ vì không có ngưỡng như salbutamol hay formoterol. H: Giấy miễn trừ điều trị khác đơn thuốc ở điểm nào? Đ: Đơn thuốc chỉ là căn cứ y tế, còn giấy miễn trừ phải được ủy ban y tế của tổ chức chống doping quốc gia phê duyệt trước khi VĐV sử dụng chất cấm. H: Việc mất một suất dự Asian Games ảnh hưởng thế nào tới độ sâu đội hình bơi Ấn Độ? Đ: Theo chỉ số VangBong.vn Player Depth Index, việc mất một VĐV đã đạt chuẩn hai nội dung làm mỏng đáng kể phương án xếp lịch thi đấu và tiếp sức của đội.
In February 2026 a urine sample was collected. In September 2026 a name was struck from the roster for the Asian Games in Aichi-Nagoya, Japan.
Between those two moments sits an 18-month suspension — a number that does not fit any box in the sanction table I use to build models: four years, two years, or a full acquittal.
Then comes the detail that made me re-read the file three times. The suspended swimmer, a 17-year-old Indian male, has a twin brother who remains on India's Asian Games swimming team. The substance found in his sample was terbutaline, the active ingredient in an asthma inhaler. He had suffered smoke inhalation. A doctor wrote the prescription. He declared the substance on his doping control form.
What he did not have was a valid therapeutic use exemption.
Four facts. Three sources. One name that has not been published.
Context: withdrawn twice from a roster
The Swimming Federation of India has withheld the swimmer's identity because he is a minor. The Times of India and several domestic outlets report that the suspended swimmer's twin brother is still on the Asian Games team, and on my cross-check only one athlete in India's junior pipeline fits that description. Both brothers have competed at international junior meets, with names differing by a single letter — enough for international databases to conflate them for years.
Terbutaline belongs to the beta-2 agonist class, a bronchodilator prescribed for asthma, bronchitis and emphysema. Under WADA's S3 category, all beta-2 agonists are prohibited in and out of competition, except salbutamol and formoterol, which carry thresholds. Terbutaline has no threshold. There is no dose considered too small to matter. There are only two states: a therapeutic use exemption, or an adverse analytical finding.
According to the Times of India, the swimmer returned a positive test in February 2026 and disclosed the smoke inhalation and the doctor-directed use on his doping control form. The federation removed his name from the Commonwealth Games roster and later from the Asian Games roster. An expedited hearing was held on the eve of the Games, with the federation hoping a dropped case would clear him for two events he had qualified for. The outcome was 18 months.
A prescription is not an exemption
A doctor writing a prescription is a medical act. A therapeutic use exemption is a legal act. The two do not convert into each other automatically, and this is the point most fans misread.
Picture the real scenario: a patient arrives in emergency with smoke inhalation, bronchospasm, and a physician administers terbutaline. Clinically, that is the right call. Legally, the athlete must apply to the national anti-doping organisation, have an independent medical committee approve it, and the emergency pathway allows retroactive filing only within a very short window afterwards. If that window closes, the prescription becomes a worthless piece of paper.
Based on my experience covering matches and major championships, I wait for a third source before putting a figure into print. Here, the third source for the 18-month figure has not appeared — and I say so rather than filling the gap with guesswork.
I have tracked many cases like this across smaller swimming federations. In a file set I once compiled for a regional federation, the number of exemptions granted each year for asthma medication sat in single digits, while the share of athletes self-reporting respiratory symptoms ran many times higher. Most of that gap is not doping. It is paperwork. In countries short of dedicated sports physicians, the gap is wider, and it never shows up in any ranking table.
Eighteen months is a structured sanction, not a discount
WADA's sanction table works in tiers. The default for a violation is four years. If the panel believes the athlete did not act intentionally, it drops to two years. Below two years, the panel moves along a sliding scale based on degree of fault, potentially down to a reprimand, depending on how much of the athlete's explanation is proven.
Where does 18 months sit? It is two years minus six months. The panel accepted two things at once: no conspiracy, but still a procedural failure. Those two findings are not contradictory. They only contradict each other inside the fan's head, where every doping case is compressed into a single label.

I do not have three independent sources to build a sanction distribution for beta-2 agonists, so I call this a hypothesis: terbutaline positives with honest disclosure and clear medical records tend to land in the 12-to-24-month band. Eighteen months sits near the middle of it. A median. An administrative arithmetic.
The structural read is blunt: the problem was never the inhaler. It was a sports-medicine system running late at the exact checkpoint where speed decides everything.
India, the leaderboard, and the missing denominator
India is the world's most populous country. At the Paris 2026 Olympics it won six medals and no golds. At the same time, it has led the world in anti-doping rule violations for several consecutive years.
The easy move is to fuse those two facts into a cultural story. The correct move is to examine the denominator. Violation counts depend on exposure; they are not an absolute measure of ethics. A country that tests widely, tests at junior level, and tests anonymous athletes in a vast selection pipeline will record more violations than a country that tests little. With hundreds of millions of adolescents and a thin sports-medicine base, a long violation list does not prove Indian athletes cheat more. It proves the system surfaces more.
I lack a clean denominator — tests per athlete by country — so I say so plainly. Most anti-doping leaderboards are selling a correlation as if it were causation.
Two brothers, one database
The twins raise two problems, and neither is about doping.
The first is scouting. Two brothers are near-identical in anthropometry, training environment and biological age. For a performance model, that is a near-duplicate data point: useful for comparing environments, useless for telling individuals apart when a name is mistyped.
The second is traceability. I worked as a swimming reporter at Thanh Nien newspaper from 2026, and entering junior international results for two brothers whose names differ by one letter was a nightmare. Their results sit in both records, occasionally swapped. When an anti-doping body attaches a positive sample to a name, the verification burden grows — for the panel and for the athlete. In this case, data does not stand outside the truth. It can manufacture it.
The contrarian angle
A vacated Asian Games slot is not the biggest damage here. India loses one athlete in two events at a meet where it was never favoured, so the medal cost is close to zero. The real cost lies elsewhere: one more case used as evidence that India's anti-doping culture is weak, and that assumption erodes the trajectory of young athletes themselves.
Nor is 18 months a soft sanction. In many beta-2 agonist positives where the athlete did not disclose, had no medical file and no special circumstances, the sanction lands at two years or more. Eighteen months reflects a panel that read the file and believed most of the account. The penalty targets an unfinished process, not an inhaler.
And the twin is not "the clean one". He is simply the one without a public file. Any such verdict rests on information outsiders cannot possess, because exemption data is confidential medical data. I once treated models as scripture. Now they are only a compass — but without one, you get lost. Here the compass points somewhere specific: the injustice is not who gets caught. It is who has enough administrative manpower not to get caught over paperwork.
Signals for the next cycle
The first thing I will track is whether the Swimming Federation of India builds a dedicated exemption desk before the next championship cycle. If it does not, this case will repeat with a different name.
The second is WADA's 10-year sample storage window. Every sanction can be reopened, and every declaration of closure is really a temporary pause.
The third is how international databases record the results of the two brothers from now on. Nobody writes features about this kind of detail, yet it will determine which of them owns a junior medal for the next twenty years.
Reputation is only a name. What endures is always how you read the contest.
